177 related articles for article (PubMed ID: 460449)
1. [Chemotherapy of leprosy. I. Sulfones and sulfonamides].
Leiker DL
Ned Tijdschr Geneeskd; 1979 Jun; 123(23):969-72. PubMed ID: 460449
[No Abstract] [Full Text] [Related]
2. [Diucifon and dimocifon in the combined therapy of leprosy (14-year observation)].
Goloshchapov NM; Bazurov GI; Khromova EB; Steklovskiĭ VK; Goloshchapova FN
Vestn Dermatol Venerol; 1988; (7):18-22. PubMed ID: 3064483
[No Abstract] [Full Text] [Related]
3. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
[TBL] [Abstract][Full Text] [Related]
4. Dapsone drug resistance in the MDT era.
Roche PW; Neupane KD; Failbus SS; Butlin CR
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097
[No Abstract] [Full Text] [Related]
5. Therapy of leprosy with sulfonamides. Emphasis on the use of weekly doses.
Opromolla DV
Int J Lepr Other Mycobact Dis; 1971; 39(2):467-70. PubMed ID: 4948085
[No Abstract] [Full Text] [Related]
6. Clofazimine and dapsone--a combination therapy in erythema nodosum leprosum syndrome.
Dutta RK
Lepr India; 1980 Apr; 52(2):252-9. PubMed ID: 7453140
[No Abstract] [Full Text] [Related]
7. Mortality due to dapsone hypersensitivity syndrome complicating multi-drug therapy for leprosy in Nepal.
Pandey B; Shrestha K; Lewis J; Hawksworth RA; Walker SL
Trop Doct; 2007 Jul; 37(3):162-3. PubMed ID: 17716505
[TBL] [Abstract][Full Text] [Related]
8. Multidrug therapy (MDT) and leprosy control.
Noordeen SK
Indian J Lepr; 1990; 62(4):448-58. PubMed ID: 2086680
[No Abstract] [Full Text] [Related]
9. A Traditional NSAID Aspirin along with Clofazimine in Erythema Nodosum Leprosum Reaction: Study of Six Cases.
Sharma PK; Singh DK
Indian J Lepr; 2016 Sep; 87(4):249-253. PubMed ID: 29762954
[TBL] [Abstract][Full Text] [Related]
10. [Combination chemotherapy in leprosy].
Leiker DL
Ned Tijdschr Geneeskd; 1986 Oct; 130(43):1926-9. PubMed ID: 3774040
[No Abstract] [Full Text] [Related]
11. [Antibacterial chemotherapy in leprosy: principles, objectives and recommendations].
Sansarricq H
Acta Leprol; 1986; 4(3):355-62. PubMed ID: 3551474
[No Abstract] [Full Text] [Related]
12. [Chemotherapy of leprosy. II. Sulfones and sulfonamides].
Leiker DL
Ned Tijdschr Geneeskd; 1980 Jan; 124(2):46-8. PubMed ID: 7374822
[No Abstract] [Full Text] [Related]
13. Srategy of leprosy control.
WHO Chron; 1978 May; 32(5):193-9. PubMed ID: 664625
[No Abstract] [Full Text] [Related]
14. Lepromatous leprosy in Saudi female from central region.
al-Majed S
J Hyg Epidemiol Microbiol Immunol; 1991; 35(2):163-6. PubMed ID: 1940331
[TBL] [Abstract][Full Text] [Related]
15. Controlled long-term therapy of leprosy with B663 (lamprene, clofazimine) compared with DDS.
Tolentino JG; Rodriquez JN; Abalos RM
Int J Lepr Other Mycobact Dis; 1974; 42(4):416-418. PubMed ID: 4617720
[No Abstract] [Full Text] [Related]
16. Relapses in leprosy patients treated with rifampicin plus dapsone after varying periods of dapsone monotherapy.
Li HY; Ran SP; Weng XM; Li TG; Deng XH; Li FT
Indian J Lepr; 2001; 73(1):1-10. PubMed ID: 11326592
[TBL] [Abstract][Full Text] [Related]
17. Lack of response to WHO/MDT; a case report.
Habtemariam H; Guebre-Xabier M
Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):632-4. PubMed ID: 8151198
[No Abstract] [Full Text] [Related]
18. The management of leprosy.
Boughton CR; Lloyd AR
Med J Aust; 1987 Jun; 146(11):593-9. PubMed ID: 3302636
[No Abstract] [Full Text] [Related]
19. [Supidimide, a non-teratogenic thalidomide analog for the treatment of leprosy reaction?].
Sheskin J; Mückter H; Frankus E
Hautarzt; 1983 Apr; 34(4):168-70. PubMed ID: 6853166
[No Abstract] [Full Text] [Related]
20. Management of complications following leprosy: an evolving scenario.
Sehgal VN; Sardana K; Dogra S
J Dermatolog Treat; 2007; 18(6):366-74. PubMed ID: 18058495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
